%20(2).png){kind=logo}
Havas today announced a strategic investment and partnership with Ostro, the trailblazing AI-powered engagement platform built for the life sciences industry
Join Ostro at Future Pharma in Boston this June to redefine AI-powered commercial strategies to improve the patient experience.
Ostro, the leading provider of AI-powered engagement solutions for life sciences, has filed a provisional U.S. patent application (US 19/036,907) titled "Machine Learning-Based Algorithms for Improved Generation of a Search Response."
Fireside Chat: Hosted by Kristina Kirby. This May 20th discussion will explore AI-powered engagement strategies for consumers and HCPs.
Brand.com’s are connecting HCPs to information, with fewer hoops to jump through, courtesy of new digital tools promising to tee up personalized content.
Inside Chase Feiger's newest Forbes piece, he sits down with Giles Platford, President of the Takeda Plasma-Derived Therapies Business Unit, to discuss the challenges and breakthroughs shaping the future of PDTs.
Ostro, a leader in AI-driven digital engagement solutions, is proud to spotlight its partnership with the Desmoid Tumor Research Foundation (DTRF) as we approach Rare Disease Month, a meaningful time to foster awareness and champion impactful innovation.
AI can transform pharmaceutical marketing by scaling personalized content development and delivery and optimizing processes. But it must be deployed responsibly, with clear guardrails to ensure compliance.
We’re proud to be a Diamond Partner for Fierce Pharma Engage 2025! Join Ostro Co-Founder Chase Feiger as he shares how pharma marketers can move beyond personalization with AI-powered engagement that drives real-time decisions and high-value actions.
.svg)